Home  >  Research  >  Labs  >  Clinical Science Division  >  CCREM

RESEARCH OVERVIEW

The Centre for Clinical Research in Emergency Medicine (CCREM) is a unique unit established at Royal Perth Hospital, Perth, Western Australia that brings together clinical staff working in the Emergency Department (ED) and laboratory scientists using immunological and molecular biological techniques. CCREM investigates a number of conditions within the spectrum of disease treated by EDs including,

  • sepsis
  • trauma
  • anaphylaxis
  • geriatric syndromes
  • chest pain
  • snake and spider envenoming
  • drug overdose

Clinical information and special blood samples are collected from patients while they are in the ED, providing an invaluable tool for investigating the underlying mechanisms of disease.
CCREM is the leading clinical trials centre for Emergency Medicine in Australasia, with the only wet lab within an Emergency Department. As such, its core research themes are:

  • Determining the cellular mechanisms that amplify anaphylactic, septic and haemorrhagic shock
  • Improving outcomes from severe sepsis and respiratory emergencies (specifically septic shock, pneumonia, anaphylaxis, pneumothorax and thromboembolic disease) through a series of multicentre clinical trials informed by ongoing mechanistic research
  • Admission avoidance for elderly patients and others with complex needs
  • Evaluating the effectiveness of systems of care.

Over the last 5 years, research by CCREM has resulted in major changes and/or justifications for clinical approaches to chest pain, critical illness, anaphylaxis, snake envenoming and redback spider bite. Ongoing studies are expected to have similar impacts in the management of sepsis, respiratory emergencies and acute presentations in the elderly. CCREM studies also address economics and avoiding unnecessary (or even harmful) use of drugs and interventions.

Click here for more information.

LATEST NEWS

Going bald to battle sarcoma

Perkins alumnus, Matthew Eton, is facing an important fight. In May this year, Matthew was diagnosed with synovial sarcoma – a subtype of the rare bone and connective tissue cancer…

Read More

Improving treatment for severe leukaemia

Researchers from the Harry Perkins Institute of Medical Research have collaborated on a major project to help in the development of a new and improved way to treat the poor-prognosis…

Read More

Australian drug chosen for global trial to treat COVID-19  

A drug developed by Perkins and UWA spinout company Dimerix will be used in a global trial to treat patients who have Acute Respiratory Distress Syndrome (ARDS) as a result…

Read More

I'M LOOKING FOR

RESEARCH PROJECTS

TEAM MEMBERS

PUBLICATIONS